- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GILD
Recent news which mentions GILD
Kite Pharma's CAR T-Cell Therapy Wins European Approval In Refractory Leukemia Setting
September 07, 2022
Tickers
GILD
From Benzinga
Gilead's Breast Cancer Drug Improves Progression-Free Survival in HR+/HER2- Metastatic Breast Cancer
September 06, 2022
Tickers
GILD
From Benzinga
3 Great Dividend Stocks to Buy in September
September 03, 2022
From Motley Fool
Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback
September 02, 2022
From Benzinga
Everest Medicines Descends To New Depths On String Of Bad News
September 01, 2022
From Benzinga
Want $1,100 in Passive Income? Invest $20,000 in These 2 Stocks
August 25, 2022
From Motley Fool
Gilead's Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays
August 22, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 19, 2022
From Benzinga
From Benzinga
Caribou's Blood Cancer Candidate Shows Response Rates Better Than Novartis,' This Analyst Writes
August 18, 2022
From Benzinga
Can Faraday Future (FFIE) Stock Turn Its Cash Crunch Around?
August 16, 2022
From InvestorPlace
SoftBank Just Gave Nu Holdings (NU) Stock a Big Boost
August 16, 2022
From InvestorPlace
What Is Going on With Gilead Sciences (GILD) Stock Today?
August 16, 2022
Tickers
GILD
From InvestorPlace
After Surprise Overall Survival Data In Metastatic Breast Cancer, Gilead Takes Complete Rights To Trodelvy
August 16, 2022
Tickers
GILD
From Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
From Benzinga
Why Gilead Sciences Stock Was a 5% Winner Today
August 15, 2022
From Motley Fool
From Benzinga
Gilead Shares Climb On Positive Interim Analysis From Late-Stage Breast Cancer Study
August 15, 2022
Tickers
GILD
From Benzinga
7 Growth Stocks to Buy After a 20% Correction
August 15, 2022
From InvestorPlace
3 Best Funds for Aggressive Investors
August 11, 2022
From InvestorPlace
3 Healthcare Stocks With High Profit Margins
August 10, 2022
From Motley Fool
Tickers
GILD
From Best Stocks
2 Reasons This Beaten-Down Stock Could Be About to Rebound
August 07, 2022
Tickers
GILD
From Motley Fool
From Benzinga
Recession Investing: 5 High Yield Dividend Stocks For A Downturn
August 03, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.